UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky

Cellular and molecular neurobiology, 2018-01, Vol.38 (1), p.13-24

2018

Volltextzugriff (PDF)

Homeostatic systems, biocybernetics, and autonomic neuroscience

Autonomic neuroscience, 2017-12, Vol.208, p.15-28

2017

Volltextzugriff (PDF)

Corrigendum to “Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy” [Parkinsonism Relat. Disord. 35 (2017) 88–91]

Parkinsonism & related disorders, 2017-06, Vol.39, p.95-95

2017

Volltextzugriff (PDF)

Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy

Parkinsonism & related disorders, 2017-02, Vol.35, p.88-91

2017

Volltextzugriff (PDF)

Autoimmunity-associated autonomic failure with sympathetic denervation

Clinical autonomic research, 2017-02, Vol.27 (1), p.57-62

2017

Volltextzugriff (PDF)

Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies

Parkinsonism & related disorders, 2016-10, Vol.31, p.79-86

2016

Volltextzugriff (PDF)

3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells

Neurochemical research, 2016-09, Vol.41 (9), p.2173-2178

2016

Volltextzugriff (PDF)

Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells

The Journal of pharmacology and experimental therapeutics, 2016-02, Vol.356 (2), p.483-493

2016

Volltextzugriff (PDF)

Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration

Parkinsonism & related disorders, 2015-09, Vol.21 (9), p.1013-1022

2015

Volltextzugriff (PDF)

Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy

Parkinsonism & related disorders, 2015-06, Vol.21 (6), p.567-572

2015

Volltextzugriff (PDF)

Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease

Journal of neurochemistry, 2015-04, Vol.133 (1), p.14-25

2015

Volltextzugriff (PDF)

Rotenone Decreases Intracellular Aldehyde Dehydrogenase Activity: Implications for the Pathogenesis of Parkinson Disease

Journal of neurochemistry, 2015-02, Vol.133 (1), p.14-25

2015

Volltextzugriff (PDF)

Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy

Clinical autonomic research, 2015-02, Vol.25 (1), p.61-67

2015

Volltextzugriff (PDF)

Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders

Pharmacology & therapeutics (Oxford), 2014-12, Vol.144 (3), p.268-282

2014

Volltextzugriff (PDF)

A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease

Journal of neurochemistry, 2014-10, Vol.131 (2), p.219-228

2014

Volltextzugriff (PDF)

A Vesicular Sequestration-to-Oxidative Deamination Shift in Myocardial Sympathetic Nerves in Parkinson Disease

Journal of neurochemistry, 2014-06, Vol.131 (2), p.219-228

2014

Volltextzugriff (PDF)

Catecholamines and stress: proceedings of the International Symposium on Catecholamines and Stress, held in Bratislava, Czechoslovakia, July 27-30, 1975

2014

Volltextzugriff (PDF)

Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease

Journal of neurochemistry, 2013-09, Vol.126 (5), p.591-603

2013

Volltextzugriff (PDF)

Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease

Journal of neurochemistry, 2012-12, Vol.123 (6), p.932-943

2012

Volltextzugriff (PDF)

Vesicular uptake blockade generates the toxic dopamine metabolite 3,4‐dihydroxyphenylacetaldehyde in PC 12 cells: relevance to the pathogenesis of Parkinson's disease

Journal of neurochemistry, 2012-12, Vol.123 (6), p.932-943

2012

Volltextzugriff (PDF)

Vesicular Uptake Blockade Generates the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells: Relevance to the Pathogenesis of Parkinson Disease

Journal of neurochemistry, 2012-10, Vol.123 (6), p.932-943

2012

Volltextzugriff (PDF)

Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases

The Journal of clinical investigation, 2011-08, Vol.121 (8), p.3320

2011

Volltextzugriff (PDF)

Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases

The Journal of clinical investigation, 2011-08, Vol.121 (8), p.3320-3330

2011

Volltextzugriff (PDF)

Effects of Carbidopa and Entacapone on the Metabolic Fate of the Norepinephrine Prodrug L-DOPS

Journal of clinical pharmacology, 2011-01, Vol.51 (1), p.66-74

2011

Volltextzugriff (PDF)

Hypertension Increases Cerebral 6-18F-Fluorodopa-Derived Radioactivity

The Journal of nuclear medicine (1978), 2009-09, Vol.50 (9), p.1479-1482

2009

Volltextzugriff (PDF)

1 – 25 von 521

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(456)
Mit Volltextzugriff
(406)

Publikationsform

Sprache

Englisch
(521)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(347)
Life Sciences & Biomedicine
(310)
Animals
(256)
Male
(224)
Rats
(197)
Humans
(152)
Neurosciences & Neurology
(111)
Biological And Medical Sciences
(108)
Neurosciences
(97)
Pharmacology & Pharmacy
(97)
Female
(84)
Norepinephrine - Metabolism
(81)
Norepinephrine - Blood
(72)
Norepinephrine
(66)
Adult
(59)
Medical Sciences
(56)
Middle Aged
(53)
Fundamental And Applied Biological Sciences. Psychology
(51)
Tritium
(51)
Aged
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Brain Research
(44)
Life Sciences
(31)
European Journal Of Pharmacology
(23)
The Journal Of Pharmacology And Experimental Therapeutics
(21)
Journal Of Neurochemistry
(20)
Biochemical Pharmacology
(18)
Science
(18)
Nature
(15)
Endocrinology
(14)
The New England Journal Of Medicine
(12)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Linking Stress, Catecholamine Autotoxicity, and Allostatic Load with Neurodegenerative Diseases: A Focused Review in Memory of Richard Kvetnansky

Homeostatic systems, biocybernetics, and autonomic neuroscience

Corrigendum to “Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy” [Parkinsonism Relat. Disord. 35 (2017) 88–91]

Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy

Autoimmunity-associated autonomic failure with sympathetic denervation

Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies

3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells

Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells

Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration

Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy

Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease

Rotenone Decreases Intracellular Aldehyde Dehydrogenase Activity: Implications for the Pathogenesis of Parkinson Disease

Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy

Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders

A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease

A Vesicular Sequestration-to-Oxidative Deamination Shift in Myocardial Sympathetic Nerves in Parkinson Disease

Catecholamines and stress: proceedings of the International Symposium on Catecholamines and Stress, held in Bratislava, Czechoslovakia, July 27-30, 1975

Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease

Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease

Vesicular uptake blockade generates the toxic dopamine metabolite 3,4‐dihydroxyphenylacetaldehyde in PC 12 cells: relevance to the pathogenesis of Parkinson's disease

Vesicular Uptake Blockade Generates the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells: Relevance to the Pathogenesis of Parkinson Disease

Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases

Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases

Effects of Carbidopa and Entacapone on the Metabolic Fate of the Norepinephrine Prodrug L-DOPS

Hypertension Increases Cerebral 6-18F-Fluorodopa-Derived Radioactivity

Suchergebnisse filtern